On April 20, 2018, Zosano Pharma Corporation filed a Current Report on Form 8-K announcing the resignation of Georgia Erbez, as Chief Business Officer and Chief Financial Officer, effective on the later to occur of the date that the Company files with the Securities and Exchange Commission a report on Form 10-Q for the first quarter of 2018 and May 15, 2018. This Form 8-K is being filed to report the execution of Ms. Erbez's separation agreement on May 10, 2018.